Does Dr. MICHAEL ABDEL-MALEK have financial conflicts of interest?

Dr. MICHAEL ABDEL-MALEK (MD) has received a total of $20,026 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $33 in personal promotional payouts (consulting, meals, travel) and $19,993 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MICHAEL ABDEL-MALEK?

According to CMS Open Payments data, Dr. MICHAEL ABDEL-MALEK received funding from JANSSEN RESEARCH & DEVELOPMENT ($19,853), ELI LILLY AND COMPANY ($140), and MERCK SHARP & DOHME ($33).

Does Dr. MICHAEL ABDEL-MALEK receive research grants or speaking fees?

Dr. MICHAEL ABDEL-MALEK has received $33 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $19,993 in clinical research grants.

DR. MICHAEL ABDEL-MALEK

MDReal-Time Hydrated

Specialty: Hospitalist

Practice Location: DUBLIN, CA 94568

NPI Number: 1952388852

LIFETIME INDUSTRY VALUE

$20,026

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABDEL-MALEK is a verified Hospitalist practitioner based in DUBLIN, CA.

Between 2021 and 2024, Dr. ABDEL-MALEK had an overall industry promotional and research financial footprint of $20,026 as recorded in the federal CMS Open Payments database.

$33 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$19,993 was allocated to sponsored clinical trials and medical research activities.

Dr. ABDEL-MALEK's primary funding source is JANSSEN RESEARCH & DEVELOPMENT, which accounts for $19,853 (representing 99.1% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

JANSSEN RESEARCH & DEVELOPMENT

Rank 1

$19,853

99.1%

ELI LILLY AND COMPANY

Rank 2

$140

0.7%

MERCK SHARP & DOHME

Rank 3

$33

0.2%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.